{"id":346966,"date":"2026-11-14T08:14:16","date_gmt":"2026-11-14T02:44:16","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/jubilant-pharmova-q2-results-fy27-pat-31-crore\/"},"modified":"2026-11-14T08:14:16","modified_gmt":"2026-11-14T02:44:16","slug":"jubilant-pharmova-q2-results-fy27-pat-31-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/jubilant-pharmova-q2-results-fy27-pat-31-crore\/","title":{"rendered":"Jubilant Pharmova Q2 Results FY27: Profit Moves Against Revenue, Revenue Rs 2,370 Cr, PAT Rs 31 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Jubilant Pharmova Q2 Results FY27 were declared on 13 November 2026, with consolidated revenue of Rs 2,370 Cr, a YoY growth of 20.52% over Rs 1,966.4 Cr a year earlier. Net profit stood at Rs 31 Cr against Rs 119.9 Cr, a decline of 74.15%, so the quarterly results show revenue and profit moving in opposite directions. Operating Profit was Rs 240.5 Cr, down 29.55% on the Consolidated basis.<\/p>\n<\/div>\n

Jubilant Pharmova Ltd<\/a> (JUBLPHARMA) Q2 Results FY27 announced on 13 November 2026, covering the company’s financial performance for the July to September quarter. The results date brought consolidated results showing revenue of Rs 2,370 Cr, up YoY, and PAT of Rs 31 Cr, down YoY. Univest presents these Jubilant Pharmova Q2 Results FY27 figures on the Consolidated basis.<\/p>\n

This Jubilant Pharmova Q2 Results review adds a results analysis covering the financial highlights, business drivers, outlook and risks. It starts with the Financial Highlights table, which places revenue, Operating Profit and net profit for the quarter beside the same quarter last year.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n